The new label for prefilled syringes, in conjunction with innovations from SCHOTT Pharma, enables integrated tamper-evidence ...
At the Cell and Gene Meeting on the Mesa, a panel discussion was held on advanced therapy production and how it demands ...
The awarded $1.7 million in funding will support the company’s preclinical and clinical progress on DMX-1001 (noribogaine), ...
The licensing of Talicia, an FDA-approved fixed-dose therapy, to key at-risk markets strategically combats an increasingly ...
The growing demand for liquid medicines is increasingly driven by the unique needs of several distinct patient groups, improving compliance in these demographics through flexible, palatable dosing ...
Siegfried Schmitt, PhD, vice-president, Technical at Parexel, answers questions on the use and benefits of real-world ...
Pharmaceutical Technology® spoke with Juliana Maynard, PhD, Head of Translational Imaging, at Medicines Discovery Catapult, ...
In the conclusion of this three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.
Pharma news on AI's role in drug development, new FDA/EMA guidance, clinical advances, MFN pricing agreements, and ongoing quality control challenges.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback